Related Experiment Video
Updated: Dec 25, 2025
13:14
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
10.9K
Next-Generation Techniques for Discovering Human Monoclonal Antibodies
A A Lushova1, M G Biazrova1, A G Prilipov2
11Institute of Immunology, Federal Medical-Biological Agency of Russia, Moscow, 115478 Russia.
Molecular Biology
|March 28, 2020
Summary
Next-generation antibody discovery platforms are revolutionizing immunotherapeutics. These advanced methods, focusing on B lymphocyte sequencing and stable cell lines, offer new avenues for developing targeted cancer and autoimmune disease treatments.
Area of Science:
- Immunology and Biotechnology
Background:
- Monoclonal antibodies are crucial therapeutics for cancer, autoimmune, and infectious diseases.
- Current antibody generation relies on hybridoma technology and phage display.
- Numerous novel antibodies are in clinical trials, expanding immunotherapeutic options.
Purpose of the Study:
- To review emerging methods for human monoclonal antibody generation.
- To highlight the advancements in next-generation antibody-discovery platforms.
Main Methods:
- Sequencing immunoglobulin genes from B lymphocytes.
- Creating stable, antibody-secreting B-cell lines.
- Utilizing next-generation antibody-discovery platforms.
Main Results:
- These novel platforms are actively being developed and refined.
- They offer alternative approaches to traditional antibody generation methods.
- The review details the outcomes achieved using these advanced techniques.
Conclusions:
- Next-generation platforms represent a significant advancement in antibody discovery.
- These methods are poised to expand the pipeline of immunotherapeutic drugs.
- Further research and application of these platforms will drive innovation in disease treatment.
